Key Facts
• Seven applicants denied Minamata disease recognition by Kumamoto and Kagoshima prefectures
• April 11: Plaintiffs and lawyers held a rally in Minamata City, Kumamoto Prefecture
• April 23: Appeal ruling scheduled at Fukuoka High Court
• Plaintiffs born and raised around Minamata City circa 1956, when disease was officially confirmed
• First trial in 2022 at Kumamoto District Court rejected claims
• Court acknowledged methylmercury exposure but denied link to sensory impairments
• Plaintiff leader Hideki Sato (71) stated government and prefectures failed to support them
• Lawyer Ryosuke Saeki argued recognition needed if defendants cannot prove other causes
• Recent Niigata Minamata disease case: Niigata District Court ruled in favor of eight plaintiffs last month
• Plaintiffs hope to leverage Niigata ruling for their own victory
Summary
Seven individuals who were denied official recognition as Minamata disease patients by Kumamoto and Kagoshima prefectures are appealing the decision. Ahead of the April 23 appeal ruling at the Fukuoka High Court, they held a rally in Minamata City demanding proper acknowledgment of their suffering. Although the 2022 first trial accepted their exposure to methylmercury, it denied a causal link to their symptoms, such as sensory impairments. Plaintiff leader Hideki Sato emphasized the lack of support from authorities despite their lifelong exposure and family recognition. Their legal team insists that unless the defendants can conclusively prove alternative causes, the plaintiffs should be recognized. The recent favorable ruling in a similar Niigata Minamata disease case has strengthened their resolve to win recognition and compensation.
